Autologous thrombin: a new embolization treatment for traumatic intrasplenic pseudoaneurysm
- PMID: 11958322
- DOI: 10.1177/152660280200900106
Autologous thrombin: a new embolization treatment for traumatic intrasplenic pseudoaneurysm
Abstract
Purpose: To report the use of autologous thrombin for transcatheter embolization of a traumatic parenchymal splenic pseudoaneurysm.
Case report: A 15-year-old boy presented with a splenic parenchymal laceration after blunt abdominal trauma. The patient was managed conservatively but developed an intrasplenic pseudoaneurysm (grade III AAST scale) with subcapsular contrast extravasation after 3 weeks. Autologous thrombin was isolated from the patient's blood and subsequently delivered to the lesion by transcatheter superselective injection into the aneurysm neck. The patient was asymptomatic after the procedure. Nine months' follow-up demonstrated a normal spleen with completely homogenous parenchyma.
Conclusions: Autologous thrombin injection to induce thrombosis of intrasplenic pseudoaneurysm represents a new treatment option for traumatic abdominal organ injuries. Intrasac thrombosis can be safely induced to successfully restore the splenic parenchymal integrity without introduction of foreign material and associated risks of adverse reactions or infection that might accompany the use of commercial thrombin preparations.
Comment in
-
Thrombin injection for pseudoaneurysm occlusion: technical considerations.J Endovasc Ther. 2002 Feb;9(1):36-7. doi: 10.1177/152660280200900107. J Endovasc Ther. 2002. PMID: 11958323 No abstract available.